RHUMBLINE ADVISERS

Position in INFU — InfuSystem Holdings, Inc

CIK 1115418 BOSTON, MA

Position in INFU

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$184,884

+$97,960 QoQ

Shares Held

19,159

+18.6% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 98 holders

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 24% Shared 0% None 76%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,264,483,794 across 83 Medical Devices names. INFU ranks #67 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	2,820,543	$255,936,071
2	SYK	Stryker Corp	616,745	$194,175,995
3	MDT	Medtronic plc	2,213,044	$173,126,432
4	BSX	Boston Scientific Corp	2,641,843	$112,753,859
5	EW	Edwards Lifesciences Corp	1,096,770	$99,213,814
6	DXCM	Dexcom Inc	768,165	$51,735,912
7	GEHC	GE HealthCare Technologies Inc.	755,006	$48,327,934
8	STE	STERIS plc	217,541	$45,807,608

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$184,884	19,159	+18.6%	Shares	Sole	2026-08-12
2025-03-31	$86,924	16,157	+3.5%	Shares	Sole	2025-05-29
2024-12-31	$131,912	15,611	-6.9%	Shares	Sole	2025-05-29
2024-09-30	$112,385	16,774	-5.0%	Shares	Sole	2024-11-12
2024-06-30	$120,604	17,658	+13.8%	Shares	Sole	2024-08-01
2024-03-31	$132,946	15,513	+5.7%	Shares	Sole	2024-05-09
2023-12-31	$154,695	14,677	-1.6%	Shares	Sole	2024-02-08
2023-09-30	$143,722	14,909	+6.9%	Shares	Sole	2023-11-09
2023-06-30	$134,299	13,946	-14.1%	Shares	Sole	2023-08-08
2022-03-31	$159,073	16,232	+44.8%	Shares	Sole	2022-05-12
2021-12-31	$190,923	11,211	-2.8%	Shares	Sole	2022-02-10
2021-09-30	$150,235	11,530	+7.7%	Shares	Sole	2021-11-12
2021-06-30	$222,556	10,705	+4.7%	Shares	Sole	2021-08-05
2021-03-31	$208,221	10,227	-5.4%	Shares	Sole	2021-05-06
2020-12-31	$202,955	10,807	-7.9%	Shares	Sole	2021-02-10
2020-06-30	$135,387	11,732	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.